The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
9 reports and counting
Vibrant Therapeutics Raises $61M Series B | Logic-Gated Cancer Immunotherapy
Clinical-stage biotech Vibrant Therapeutics secures $61 million Series B for tumor microenvironment-activated immunotherapies.
BioNTech raises $325M Follow-on Offering at $45B valuation
BioNTech raises $325M in Follow-on Offering at $45B valuation. Immunotherapy and mRNA vaccines...
Torl Biotherapeutics raises $96M Series C at $500M valuation
Torl Biotherapeutics raises $96M in Series C at $500M valuation. Antibody-based immunotherapies for cancer patients...
BioNTech Headquarters - Office Location & Address
Discover BioNTech's headquarters at 40 Erie St, Cambridge, MA 02139. Immunotherapy developer. Learn about the office facilities and work environment.
BioNTech SE Headquarters - Office Location & Address
Discover BioNTech SE's headquarters at An der Goldgrube 12, Mainz, 55131. Immunotherapy and vaccine developer. Learn about the office facilities and work environment.
Atara Biotherapeutics Headquarters - Office Location & Address
Discover Atara Biotherapeutics's headquarters at 611 Gateway Blvd, South San Francisco, CA 94080. T-cell immunotherapy developer. Learn about the office facilities and work environment.
Abcuro Raises $200M Series C to Transform Biotech
Abcuro has secured $200M Series C in funding to accelerate growth and innovation in the biotech sector. Precision oncology company discovering and developing novel cancer immunotherapies targeting tumor microenvironments...
Torl Biotherapeutics Raises $96M in Series C
Torl Biotherapeutics, a Biotech company based in Los Angeles, CA, has raised $96M in Series C at a $500M valuation led by Cormorant Asset Management, BVF Partners.
BioNTech Raises $325M in Follow-on Offering
BioNTech, a Biotech company based in An der Goldgrube 12, Mainz 55131, Germany, has raised $325M in Follow-on Offering at a $45B valuation led by Strüngmann Family Office, MIG, Salvia, AT Impf, Pfizer.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.